PARIS (Reuters) – France has determined to widen its COVID-19 vaccine rollout to individuals aged 16-17 who might face a excessive danger of a significant sickness from the virus, mentioned the nation’s well being ministry on Thursday, because the nation progressively accelerates its vaccine programme.
The well being ministry mentioned this class of 16-17 yr olds could be allowed to get the Pfizer/BioNTech COVID vaccine from Thursday onwards.
(Reporting by Jean-Stephane Brosse; Modifying by Sudip Kar-Gupta)